A case report on<unk>  published in the A & A Practice Journal in 2020 has revealed that when milrinone is administered as an aerosol, selective pulmonary vasodilation occurs without significant changes in mean arterial pressure or systemic vascular resistance; and if used immediately after<unk> , inhaled milrinone may mitigate the pulmonary vasoconstriction. However, since the circumstances that lead to this complication are difficult to influence, treatment to resolve the symptoms and deteriorating vascular conditions can improve outcomes.
Amniotic fluid embolism
Traumatic asphyxia
Artificial rupture of membranes
Cerebrospinal fluid leak
Foetal cerebral redistribution
Neonatal meningitis
Rupture of membranes
Fetal-maternal haemorrhage